Gabelli Funds’s Vigil Neuroscience VIGL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-1,189,528
Closed -$9.46M 1306
2025
Q2
$9.46M Buy
+1,189,528
New +$5.33M 0.07% 327

Other funds holding VIGL

Gabelli Funds's VIGL Position: Q3 2025 in Review

Gabelli Funds sold out of Vigil Neuroscience (VIGL) in Q3 2025, closing a stake of 1,189,528 shares — an estimated $9.46M sold.

Gabelli Funds first reported a position in VIGL in Q2 2025 and held it in 1 quarter. The position peaked at $9.46M in Q2 2025. 2 funds tracked by Wall St. Rank hold VIGL as of Q3 2025.

  • Gabelli Funds reported no remaining Vigil Neuroscience position as of Q3 2025 after selling out during the quarter.
  • Gabelli Funds sold 1,189,528 Vigil Neuroscience shares in Q3 2025, an estimated $9.46M.
  • Gabelli Funds first reported a position in Vigil Neuroscience in Q2 2025 and held it in 1 quarter.
  • Gabelli Funds's Vigil Neuroscience position peaked at $9.46M in Q2 2025.
  • 2 funds tracked by Wall St. Rank held Vigil Neuroscience as of Q3 2025.

Based on Gabelli Funds's 13F filing for Q3 2025, filed 12 Nov 2025.